Cargando…
No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts
A combined endpoint measure to define no evidence of disease activity (NEDA) is becoming increasingly appealing in the treatment of multiple sclerosis (MS). Initial efforts using a 3 parameter NEDA monitored disease activity using clinical and MRI lesion data. Later refinements, introduced more rece...
Autor principal: | Pandit, Lekha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613429/ https://www.ncbi.nlm.nih.gov/pubmed/31359933 http://dx.doi.org/10.4103/aian.AIAN_159_19 |
Ejemplares similares
-
Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology
por: Bhatia, Rohit, et al.
Publicado: (2020) -
Improving quality, affordability, and equity of multiple sclerosis care
por: Langer‐Gould, Annette, et al.
Publicado: (2021) -
Can We Treat Secondary Progressive Multiple Sclerosis Now?
por: Bhatia, Rohit, et al.
Publicado: (2019) -
Chronic cerebrospinal venous insufficiency in Multiple Sclerosis: A note for caution
por: Bhatia, Rohit, et al.
Publicado: (2012) -
Goals, challenges, and next steps in transdisciplinary fisheries research: perspectives and experiences from early-career researchers
por: Nyboer, Elizabeth A., et al.
Publicado: (2022)